Mark has more than twenty years of experience managing pharmaceutical strategic partnerships, reconfiguring infrastructures, and integrating acquired companies with strong business development acumen. He previously held various leadership roles at Aralez Pharmaceuticals, Auxilium Pharmaceuticals, and Otsuka Pharmaceuticals. Mark has a BA from the State University of New York and an MBA from New York University Stern School of Business.